Stem cell therapies, regenerative medicine, tissue engineering, and cellular reprogramming
188 articoli
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
New research in Nature Aging suggests tissue mechanical softness is a critical factor enabling cellular regeneration, with major implications for aging biology.
Vai più a fondo su come vengono costruiti gli esosomi, cosa trasportano e come il loro carico molecolare riprogramma le cellule riceventi — con implicazioni per la rigenerazione, l'invecchiamento e le terapie emergenti.
Harvard's CellCartographer uses machine learning to identify optimal transcription factor combinations for rapid, high-efficiency cell reprogramming.
Kyoto researchers created jawbone-like organoids from human iPSCs, recapitulating mandibular development and modeling fragile bone disease.
Chinese researchers decode how chemical cocktails alone can convert adult human cells into pluripotent stem cells, bypassing gene editing.
A review of iPSC-based regenerative medicine charts the path from Parkinson's disease models to real-world cell replacement therapies.
Scopri gli esosomi — i "messaggi di testo" microscopici che le tue cellule si inviano per coordinare guarigione, invecchiamento e riparazione in tutto il corpo.
Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.
A comprehensive review maps how mesenchymal stem cells and their exosomes combat Alzheimer's, atherosclerosis, osteoporosis, and ovarian failure.
A novel photoactivatable drug system uses NK immune cells to eliminate aging joint cells, reducing osteoarthritis progression in mice.
Combining nanoparticles with mesenchymal stem cells could finally overcome the poor survival and differentiation that limits cartilage regeneration.
